D. Carreon
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Neural and Behavioral Psychology Studies 2
- Functional Brain Connectivity Studies 2
-
- Schizophrenia research and treatment 2
- Co-authors
- Steven G. Potkin (9 shared papers)Yi Jin (3 shared papers)Gus Alva (3 shared papers)Bala Gulasekaram (2 shared papers)Glenn Richmond (2 shared papers)B. Gerber (2 shared papers)Júlia Costa (2 shared papers)Aaron S. Kemp (1 shared paper)
- Journals
- Schizophrenia Bulletin (1 paper)European Neuropsychopharmacology (1 paper)Biological Psychiatry (1 paper)Molecular Psychiatry (1 paper)Canadian Medical Association Journal (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
D. Carreon
10 papers receiving 396 citations
Peers
Comparison fields: 5 of 59
- Psychiatry and Mental health 213
- Biological Psychiatry 29
- Neurology 73
- Cognitive Neuroscience 60
- Cellular and Molecular Neuroscience 48
Countries citing papers authored by D. Carreon
This map shows the geographic impact of D. Carreon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Carreon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Carreon more than expected).
Fields of papers citing papers by D. Carreon
This network shows the impact of papers produced by D. Carreon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Carreon. The network helps show where D. Carreon may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Carreon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. | 1994 | 152 |
| 2 | 2005 | 99 | |
| 3 | 2003 | 84 | |
| 4 | 1994 | 43 | |
| 5 | 2009 | 22 | |
| 6 | Measuring the psychological construct of control. Discriminant, divergent, and incremental validity of the Shapiro Control Inventory and Rotter's and Wallstons' Locus of Control Scales. | 1993 | 12 |
| 7 | 1989 | 3 | |
| 8 | 1993 | 2 | |
| 9 | 1996 | 2 | |
| 10 | Predicting Clinical Antipsychotic Doses from Preclinical and PET studies: A Case Study with Asenapine | 2003 | 1 |
| 11 | Incidencia de cáncer de mama, 1980-2006: roles combinados de la terapia hormonal menopáusica, la mamografía y el estado del receptor de estrógeno | 2007 | 0 |
About D. Carreon
D. Carreon is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Neurology and Clinical Psychology, having authored 11 papers that have together received 420 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (2 papers), Neural and Behavioral Psychology Studies (2 papers), Functional Brain Connectivity Studies (2 papers), Folate and B Vitamins Research (1 paper), Transcranial Magnetic Stimulation Studies (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), Nerve injury and regeneration (1 paper) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper). The work is most often cited by research in Psychiatry and Mental health (213 citations), Biological Psychiatry (29 citations), Neurology (73 citations), Cognitive Neuroscience (60 citations) and Cellular and Molecular Neuroscience (48 citations). D. Carreon has collaborated with scholars based in United States and Canada. Frequent co-authors include Steven G. Potkin, Yi Jin, Gus Alva, Bala Gulasekaram, Glenn Richmond, B. Gerber, Júlia Costa, Aaron S. Kemp, W.E. Bunney and Joseph C. Wu. Their work appears in journals such as Schizophrenia Bulletin, European Neuropsychopharmacology, Biological Psychiatry, Molecular Psychiatry and Canadian Medical Association Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.